Akamai Technologies, Inc.
93.53USD
+2.4000 (+2.63%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on AKAM.
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 3.6B | 3.8B | 4.0B | 4.2B | 4.5B | 5.2B |
| Q1 | 903.6M | 915.7M | 987.0M | 1.0B | 1.1B | — |
| Q2 | 903.3M | 935.7M | 979.6M | 1.0B | 1.1B | — |
| Q3 | 881.9M | 965.5M | 1.0B | 1.1B | 1.1B | — |
| Q4 | 927.8M | 995.0M* | 1.0B* | 1.1B* | 1.2B | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 3.26 | 3.52 | 3.27 | 3.07 | 6.64 | 6.84 |
| Q1 | .820 | .620 | 1.11 | .820 | .710 | — |
| Q2 | .850 | .840 | .860 | .710 | .520 | — |
| Q3 | .780 | 1.04 | .380 | .970 | 1.67 | — |
| Q4 | .820 |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
Revenue to net income
| 1.04* |
| .906* |
| .579* |
| 1.78 |
| — |
Debt level and coverage